Spring 2022 has been very productive season for Rett scientists bringing hope to our families. We are happy to share some exciting news with our community. 29th March 2022 Taysha gene therapies annoucned that their Clinical Trial Application (CTA) had been approved by Health Canada. TSHA-102, which utilises the novel miRARE platform to regulate transgene expression […]
Airett Conference
Airett are delighted to announce that after an absence of two years they will be hosting a hybrid event on 10th and 11th June 2022. THE THEMES OF THE CONFERENCE Scientists and researchers will provide updates on the latest clinical trials and what is on the horizon. A special attention will be paid to the […]
Support for Families in Ukraine
You are not alone! We know that nothing will ever compensate the tragedy of suffering a war, but we´ll do our best to support all Rett families who had to face it. Wether you are a family in need or someone who wants to help, please check the information bellow. Clearly things can change quickly […]
Inna´s victory
Inna is 9 years old and lives in France with her family. Her mother, Elsa Delhelle Gasnier, says that since Inna was diagnosed with Rett syndrome, their family schedule got filled with never ending medical appointments, which many times feel like a stressfull battlefield: “Appointments, appointments, always appointments… Good news and bad news… When we […]
AIRETT International Call for Research Projects
AIRETT is delighted to announce its second international call for base, clinical and rehabilitation research projects on Rett syndrome. They believe that the work of different research centres (even with international collaborations) could help speed work towards a cure for the disorder. Research groups can ask for up to 100,000 euros for a two-year project. […]
Trofinetide Update
Could Trofinetide be the first drug to be approved specifically to treat Rett syndrome? On 7th December 2021, Neuren announced positive ‘top line’ results for from the Phase 3 trial in Rett syndrome. The drug had met both it’s endpoints demonstrating an improvement on the Rett Syndrome Behaviour Questionnaire and the Clinical Global Impression of […]
General Assembly activity report and recordings of presentations
First and foremost, thank you everyone who joined our GA meeting. Even though online events have their limitations, we are very happy about your active participation and engagement in the discussions. For everyone who participated and would like to look back, as well as for those who missed it, please find below the interactive slides […]
Covid Boosters for People with Rett Syndrome
Lots of families are considering whether their daughter/son with Rett syndrome should have the booster Covid jab. Here Ana Abdala, member of our Scientific Advisory Board, gives her view which we hope you will find helpful. ‘A search of multiple databases did not return any specific studies of COVID vaccination in people who have Rett […]
General Assembly 2021
Please join us for our General Assembly 27th November 10am to 1.30pm CET The agenda and invitation with relevant papers have been emailed to our members. Please contact us in case you haven´t received it and would like it to be resent. We are delighted that two members of the Scientific Advisory Board will be […]
Hello Camille!
In the second of our Family Focus features, Laetitia and Nicolas from Belgium, share their story about new diagnosis and how meeting a family who were so positive really helped in those early days. ‘Since her birth, Camille has been our sun during the day as well as our little star at night … she […]